What is Lantern Pharma Inc. Common Stock's Market Cap?

Lantern Pharma Inc. Common Stock's Market Cap is $23.0M, based on as-reported figures from SEC (XBRL) filings.

What is Lantern Pharma Inc. Common Stock's Enterprise Value?

Lantern Pharma Inc. Common Stock's Enterprise Value is $15.7M, based on as-reported figures from SEC (XBRL) filings.

What is Lantern Pharma Inc. Common Stock's EV / EBITDA?

Lantern Pharma Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Lantern Pharma Inc. Common Stock's Net Income (TTM)?

Lantern Pharma Inc. Common Stock's Net Income (TTM) is -$18.7M, based on as-reported figures from SEC (XBRL) filings.

What is Lantern Pharma Inc. Common Stock's EBITDA?

Lantern Pharma Inc. Common Stock's EBITDA is -$15.5M, based on as-reported figures from SEC (XBRL) filings.

What is Lantern Pharma Inc. Common Stock's Diluted EPS (TTM)?

Lantern Pharma Inc. Common Stock's Diluted EPS (TTM) is -1.46, based on as-reported figures from SEC (XBRL) filings.

What is Lantern Pharma Inc. Common Stock's Net Debt?

Lantern Pharma Inc. Common Stock's Net Debt is -$7.4M, based on as-reported figures from SEC (XBRL) filings.

Lantern Pharma Inc. Common Stock (LTRN) Financial Statements

Lantern Pharma Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00GM6LK26

XNAS · usd

1.80▼ 0.04 (-2.17%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close1.84

Day's Range1.83 – 2.01

52-Week Range1.11 – 4.70

Volume242.4K

Avg Volume118.2K

Share Statistics

Shares Outstanding

Employees16

ExchangeXNAS

Listed2020-06-11

Share count as of August 10, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Lantern Pharma Inc. Common Stock (LTRN)

What is Lantern Pharma Inc. Common Stock's Market Cap?: Lantern Pharma Inc. Common Stock's Market Cap is $23.0M, based on as-reported figures from SEC (XBRL) filings.
What is Lantern Pharma Inc. Common Stock's Enterprise Value?: Lantern Pharma Inc. Common Stock's Enterprise Value is $15.7M, based on as-reported figures from SEC (XBRL) filings.
What is Lantern Pharma Inc. Common Stock's EV / EBITDA?: Lantern Pharma Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Lantern Pharma Inc. Common Stock's Net Income (TTM)?: Lantern Pharma Inc. Common Stock's Net Income (TTM) is -$18.7M, based on as-reported figures from SEC (XBRL) filings.
What is Lantern Pharma Inc. Common Stock's EBITDA?: Lantern Pharma Inc. Common Stock's EBITDA is -$15.5M, based on as-reported figures from SEC (XBRL) filings.
What is Lantern Pharma Inc. Common Stock's Diluted EPS (TTM)?: Lantern Pharma Inc. Common Stock's Diluted EPS (TTM) is -1.46, based on as-reported figures from SEC (XBRL) filings.
What is Lantern Pharma Inc. Common Stock's Net Debt?: Lantern Pharma Inc. Common Stock's Net Debt is -$7.4M, based on as-reported figures from SEC (XBRL) filings.